Clinical Trials Logo

Good Pasture Syndrome clinical trials

View clinical trials related to Good Pasture Syndrome.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05679401 Recruiting - Clinical trials for Anti-Glomerular Basement Membrane Antibody Disease

A Study With Imlifidase in Anti-GBM Disease

GOOD-IDES-02
Start date: December 22, 2022
Phase: Phase 3
Study type: Interventional

An open-label, controlled, randomised, multi-centre Phase 3 trial evaluating renal function in patients with severe anti-GBM disease comparing imlifidase and standard of care (SoC) with SoC alone. All patients will remain in the trial for 24 months.

NCT ID: NCT03801135 Recruiting - Clinical trials for Guillain-Barre Syndrome

Changes in Haemostasis After Therapeutic Plasmapheresis With Citrate Anticoagulation

Start date: October 3, 2018
Phase: N/A
Study type: Interventional

Plasma exchange procedures remove procoagulant and anticoagulant factors. Every procedure increases the risk of bleeding and repeated procedures increase the risk of bleeding mostly because lower fibrinogen levels. The aim of study is to define coagulation status of patient after plasmapheresis with different laboratory tests and to investigate the possibility of fibrinogen concentrate replacement for the correction of induced coagulation disorder.